Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Renal Drug Clearance: Comparison Between Renal Excretion Methods01:08

Renal Drug Clearance: Comparison Between Renal Excretion Methods

Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Cryptosporidiosis in immunosuppressed renal transplant patient].

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2021
Same author

More Than 1000 Kidney Transplants Performed in Pamplona, Navarra: Data From the Collaborative Transplant Study.

Transplantation proceedings·2016
Same author

Short-Term Outcomes of 100 Consecutive Kidney Transplantations in a 3-Year Period: A Single-Center Experience.

Transplantation proceedings·2016
Same author

[Multiple myeloma, severe hypercalcaemia, acute renal failure and multiple organ failure due to calcinosis].

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2011
Same author

[Interstitial pneumonitis from everolimus].

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2010
Same author

Treatment with cinacalcet of secondary hyperparathyroidism after renal transplantation.

Transplantation proceedings·2009

Related Experiment Video

Updated: Jul 22, 2026

Murine Kidney Transplant Technique
08:58

Murine Kidney Transplant Technique

Published on: October 20, 2015

Changes in renal transplantation: comparison between two different series.

G Gómez Marqués1, P Errasti Goenaga, F J Lavilla Royo

  • 1Renal Unit, University Hospital of Son Dureta, Palma de Mallorca, Spain. ggmarques@ono.com

Transplantation Proceedings
|January 3, 2006
PubMed
Summary

New immunosuppressives improve renal transplant outcomes despite older donors and recipients. These advanced treatments effectively counteract donor and recipient-related risks, enhancing graft survival rates.

More Related Videos

Heterotopic Renal Autotransplantation in a Porcine Model: A Step-by-Step Protocol
11:47

Heterotopic Renal Autotransplantation in a Porcine Model: A Step-by-Step Protocol

Published on: February 21, 2016

A Modified Surgical Technique for Kidney Transplantation in Mice
10:38

A Modified Surgical Technique for Kidney Transplantation in Mice

Published on: July 22, 2022

Related Experiment Videos

Last Updated: Jul 22, 2026

Murine Kidney Transplant Technique
08:58

Murine Kidney Transplant Technique

Published on: October 20, 2015

Heterotopic Renal Autotransplantation in a Porcine Model: A Step-by-Step Protocol
11:47

Heterotopic Renal Autotransplantation in a Porcine Model: A Step-by-Step Protocol

Published on: February 21, 2016

A Modified Surgical Technique for Kidney Transplantation in Mice
10:38

A Modified Surgical Technique for Kidney Transplantation in Mice

Published on: July 22, 2022

Area of Science:

  • Nephrology
  • Transplant Surgery
  • Immunology

Background:

  • Renal transplantation outcomes have improved with new immunosuppressive agents.
  • Donor and recipient profiles have shifted towards older individuals and increased comorbidities.
  • This study investigates the impact of these evolving profiles on graft survival.

Purpose of the Study:

  • To analyze the influence of donor and recipient characteristics on graft survival in renal transplant recipients.
  • To compare outcomes between historical and current immunosuppressive regimens.
  • To determine if modern immunosuppression mitigates risks associated with older donors and recipients.

Main Methods:

  • Retrospective analysis of 343 cadaveric renal transplant recipients.
  • Comparison of two series based on immunosuppression: historical and current (cyclosporine era).
  • Graft survival analyzed using actuarial methods and Cox proportional hazards modeling.

Main Results:

  • Five-year actuarial survival was 77% in the current series versus 82% in the historical series.
  • The current series exhibited higher donor/recipient age and proteinuria but significantly reduced acute rejection (21% vs. 54%) and delayed graft function (10% vs. 18%).
  • Multivariate analysis indicated a relative risk of 3.12 for graft loss in the historical series, adjusted for other variables.

Conclusions:

  • New immunosuppressive regimens effectively counteract suboptimal donor and recipient features.
  • Despite shifts in donor/recipient demographics, modern immunosuppression demonstrates a positive impact on renal transplant outcomes.
  • The study highlights the adaptability of immunosuppressive strategies to changing patient populations.